CHDI Foundation, Inc.

It took less than five years for a CNS drug discovery pact between Evotec SE and Bristol Myers Squibb Company using the German pharma’s novel iPSC platform to bring its first compound to the verge

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Tech Transfer column provides a monthly update on technology transfer deals, reporting l

Hamburg-based Evotec AG has risen like a Phoenix from the ashes in recent years to become a profitable drug-discovery business whose growth is driven by the rising trend toward outsourcing, as Big

Evotec AG hopes that buying Germany-based Bionamics GmbH will let it profitably bridge the gap between academic research projects and industry’s need for preclinical and clinical development progr